Conexeu Sciences, Inc. (CNXU) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$3.27

From 52W high−80.47%

Volume359874.00

Market cap$92.80M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataOct 19, 2026

Open

$3.27

From 52W high

−80.47%

Volume

359874.00

Market cap

$92.80M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

37.4

MomentumView details →

1D Return

+7.52%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+7.52%

YTD Return

—

1Y Return

—

RSI (14)

37.4

vs 50D SMA

−42.74%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.29

EPS Surprise

−190.00%

Beats (12Q)

0/12

Next Q EPS Est

—

Avg Surprise (4Q)

−190.00%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

Conexeu Sciences Inc. announced a $5 million private placement led by existing shareholders, management and directors, with participation from its CEO and Chief Commercial Officer.4d ago

Conexeu Sciences Inc. provided an update on its regulatory and manufacturing program supporting a planned FDA 510(k) premarket notification for its lead wound care device candidate Ten Minute Tissue.14d ago

Similar companies

Polaryx Therapeutics, Inc. Common StockPLYX Cellectis S.A.CLLS OnKure Therapeutics, Inc.OKUR Insight Molecular Diagnostics Inc.IMDX PMV Pharmaceuticals, Inc.PMVP Anixa Biosciences, Inc.ANIX Find similar companies →

Latest newsMore news →

Conexeu Sciences Inc. announced a $5 million private placement led by existing shareholders, management and directors, with participation from its CEO and Chief Commercial Officer.4d ago Conexeu Sciences Inc. provided an update on its regulatory and manufacturing program supporting a planned FDA 510(k) premarket notification for its lead wound care device candidate Ten Minute Tissue.14d ago